Comparative study between two anti hypertensive drugs ( Labetolol and Nifedipine ) to see which is more effective in controlling blood pressure in pregnancy induced hypertension.

Comparative study between Oral Nifedipine and Oral Labetolol in Management of Pregnancy Induced Hypertension. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060095

Enrollment

100

Registered

2023-11-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O13- Gestational [pregnancy-induced] hypertension without significant proteinuria

Interventions

Intervention1: Cap nifedipine 10mg: The two study groups are randomised and intervention group is given cap nifedipine 10mg given orally to lower blood pressure in pregnancy induced hypertension for e

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age more than or equal to 18years. 2. All pregnant women with hypertension whose blood pressure recording are more than or equal to 140/90mmhg more than 4 hours apart.

Exclusion criteria

Exclusion criteria: 1. Multifetal pregnancy 2. Women with pre-existing or concurrent Medical disorders like diabetes mellitus, cardiac disease, renal disease, thyrotoxicosis,haemophilia and chronic hypertension. 3 Absolute contraindications to nifedipine and labetolol. 4. Hypertensive women with intrauterine death at presentation.

Design outcomes

Primary

Measure	Time frame
Decrease in blood pressure, which drug lowers the blood pressure faster and more effectively.Timepoint: every 15 minutes after giving the drugs.	—

Secondary

Measure	Time frame
Fetal outcome, mode of delivery,complications of pregnancy induced hypertension.Timepoint: Outcome are assessed during the period of admission of patients.	—

Countries

India

Contacts

Public ContactRaj Kumari Praneshwari Devi

Regional Institute of Medical Sciences,Imphal, Manipur

Praneshwarirk1@gmail.com8974010273

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026